Hqy.O

HQY.O maintains a strong liquidity position with a current ratio of 3.27, indicating the company can cover its short-term liabilities more than three times over. The company's liquidity_fpt metric shows a cash and equivalents balance of $318.93 million, which is relatively modest compared to its long-term debt of $957.38 million, resulting in a net cash position that is negative after subtracting total debt. The price-to-book ratio of 3.31 suggests that the market values the company at a premium to its book value, reflecting investor confidence in its intangible assets and future earnings potential.

In terms of profitability, HQY.O reports a return on equity (ROE) of 10.21% and a return on assets (ROA) of 6.37%, both of which are strong indicators of efficient capital utilization and asset management. The company's operating margin, calculated as operating income of $322.46 million on revenue of $1.31 billion, stands at 24.55%, which is a robust figure for the software industry. These metrics suggest that HQY.O is performing well relative to industry standards, particularly in terms of generating profit from its operations and assets.

Geographically and segment-wise, HQY.O's revenue is concentrated in the healthcare software segment, with no disclosed geographic breakdown in the provided data. The absence of detailed geographic exposure data limits the ability to assess regional risk factors, but the company's focus on a single business segment implies a high degree of specialization and potential vulnerability to sector-specific downturns.

Looking at growth, HQY.O's revenue of $1.31 billion reflects a solid performance, but the outlook for the current fiscal year and the next is not explicitly provided in the data. The company's free cash flow of $321.12 million indicates strong cash generation, which can be reinvested in the business or returned to shareholders. However, the capital expenditure of -$48.78 million suggests that the company is not currently investing heavily in new physical assets, which may affect long-term growth potential.

Risk factors for HQY.O include a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no immediate pressure from share issuance or other dilutive events. The company's debt-to-equity ratio of 0.45 is relatively low, indicating a conservative capital structure that minimizes financial risk. However, the company's reliance on a single business segment and the absence of geographic diversification data suggest potential concentration risks that could impact its resilience to market changes.

Recent events and filings do not provide specific details in the input data, but the company's strong analyst coverage, with a mean price target of $112.20 and a median price target of $110.00, indicates positive sentiment among analysts. The mean recommendation of 1.75, with 6 strong-buy and 9 buy ratings, further supports the view that the company is well-regarded in the investment community.